Global Cardiac Resynchronization Therapy (CRT) Devices Market Size, Share and Trends Analysis 2022-2028 MedCore Includes: Cardiac Resynchronization Therapy-Pacemakers (CRT-Ps), and 1 more

In 2021, the cardiac resynchronization therapy devices market was valued at $3.2 billion and is expected to increase at a CAGR of 4.3% to reach $4.3 billion by 2028.

This research analyzed CRT companies from over 70 countries, providing valuable insights into market size, unit sales, and company market share. We used a thorough methodology to ensure accurate forecasts and provide a complete understanding of the CRT market. The report suite covers the global market for CRT devices, including CRT-P and CRT-D, providing a comprehensive overview of the industry.

MARKET REPORT DATA TYPES INCLUDED

• Unit Sales, Average Selling Prices, Market Size & Growth Trends
• Procedure Numbers
• COVID-19 Impact Analysis
• Market Drivers & Limiters
• Market Forecasts Until 2028, and Historical Data to 2018
• Recent Mergers & Acquisitions
• Company Profiles and Product Portfolios
• Leading Competitors

PROCEDURE NUMBERS

The global ICD market encompasses single-chamber, dual-chamber, and S-ICD procedures for both initial placement and replacement. Despite the decline and subsequent recovery in 2020 and 2021 caused by delayed and cancelled elective procedures, the total number of ICD procedures is expected to grow at a moderate rate over the forecast period.

GLOBAL CRT MARKET TRENDS

In 2021, the CRT device market saw an increase from the previous year. Despite being the costliest device category in the CRM industry, the additional benefits offered by CRT-D devices compared to ICDs have made them appealing enough to overcome the price difference.

GLOBAL CPT MARKET SHARE INSIGHTS

The global CPT market is dominated by three major players: Medtronic, Abbott, and Boston Scientific. In 2021, Medtronic was the market leader in CRT devices, with a strong product line for both CRT-D and CRT-P, including the CobaltTM, CromeTM, SerenaTM, SolaraTM, and other devices.

GLOBAL CPT MARKET SEGMENTATION SUMMARY

• Cardiac Resynchronization Therapy-Pacemakers (CRT-Ps)
• Cardiac Resynchronization Therapy-Defibrillators (CRT-Ds)

RESEARCH SCOPE SUMMARY

• Regions: North America (Canada, United States), Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela), Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.), Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine), Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates), Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam), Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda)
• Base Year: 2021
• Forecast: 2022-2028
• Historical Data: 2018-2021
• Quantitative Coverage: Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices.
• Qualitative Coverage: COVID19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews.
• Data Sources: Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, Internal Database.